title: H-ras dependent estrogenic effects of epidermal growth factor in the estrogen-independent breast cancer cell line MDA-MB-231.
abstract: A crosstalk between cellular estrogen response and receptor tyrosine kinase signaling has been shown in a variety of estrogen receptor (ER)-positive cell lines. We intended to examine the presence of estrogenic growth factor effects in an ER alpha-negative breast cancer cell line. By means of reporter gene assays, we investigated the activation of estrogen response elements (EREs) by epidermal growth factor (EGF) in the estrogen-unresponsive cell line MDA-MB-231. Our results demonstrate the H-ras-dependent activation of EREs after EGF treatment in this estrogen-unresponsive cell line, an effect which was not observed in the ERalpha/beta-positive breast cancer cell line MCF-7. In MDA-MB-231 cells, the transcriptional activity of an ERE-containing promotor was enhanced dose dependently by all tested EGF concentrations. This effect could be blocked by co-treatment with the epidermal growth factor receptor (EGFR) inhibitors AG1478 and ZD1839, as well as by co-transfection with a vector coding for a dominant negative H-ras mutant, but not by co-treatment with the pure antiestrogen ICI182,780. Furthermore, expression of constitutively active H-ras was shown to be sufficient to activate EREs in MDA-MB-231 cells. Our results suggest alternative utilization of ERE-mediated gene regulation in an estradiol-unresponsive breast cancer cell line in response to an EGF stimulus. This mechanism was shown to be dependent on EGFR and H-ras activity, but independent of the presence of functional ERalpha.
authors.affiliation: Department of Obstetrics and Gynecology, University of Regensburg, Regensburg, Germany. treeck@email.com
authors.forename: Oliver
authors.initials: O
authors.lastname: Treeck
authors.forename: Angela
authors.initials: A
authors.lastname: Weber
authors.forename: Michaela
authors.initials: M
authors.lastname: Boester
authors.forename: Simone
authors.initials: S
authors.lastname: Porz
authors.forename: Nicola
authors.initials: N
authors.lastname: Frey
authors.forename: Klaus
authors.initials: K
authors.lastname: Diedrich
authors.forename: Olaf
authors.initials: O
authors.lastname: Ortmann
mesh_terms: D001943:Breast Neoplasms / Q000235:genetics / Q000378:metabolism* / Q000473:pathology; D002455:Cell Division; D045744:Cell Line, Tumor; D004815:Epidermal Growth Factor / Q000494:pharmacology*; D004958:Estradiol / Q000031:analogs & derivatives* / Q000494:pharmacology; D005260:Female; D000077267:Fulvestrant; D015972:Gene Expression Regulation, Neoplastic; D011905:Genes, ras; D006801:Humans; D009376:Neoplasms, Hormone-Dependent / Q000235:genetics / Q000378:metabolism* / Q000473:pathology; D011960:Receptors, Estrogen / Q000187:drug effects / Q000378:metabolism*; D020218:Response Elements / Q000187:drug effects
chemical_list: D011960:Receptors, Estrogen; D000077267:Fulvestrant; D004958:Estradiol; D004815:Epidermal Growth Factor